Literature DB >> 36187894

Detection of 41-kDa bacterial flagellin protein by the lymphocyte transformation test-memory lymphocyte immunostimulation assay.

Basant K Puri1, Jean A Monro2.   

Abstract

BACKGROUND/
OBJECTIVES: Diagnosis of human infection by various species of the bacterial genus Borrelia is mainly reliant on serological testing, polymerase chain reaction (PCR) or culture but such serological tests have been reported to have heterogeneous sensitivities, while Borrelia PCR and culture have been reported as being of modest diagnostic value. It has been suggested that the adjunctive use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay (LTT-MELISA) may be helpful in this regard; however, the clinical usefulness of this assay has been questioned. The Borrelia immunodominant 41-kDa flagellin protein almost always gives rise to a marked human antibody response following infection. It was therefore decided to determine whether the LTT-MELISA detects the human antibody response to this antigen.
METHODS: Blood samples from consecutive patients with possible borreliosis attending a clinic were independently tested by both Western blots and LTT-MELISA.
RESULTS: After omitting cases with indeterminate Western blot results and equivocal LTT-MELISA results, multiple linear regression modelling demonstrated that the 41-kDa flagellin immunoglobulin (Ig) M level was predictable from two LTT-MELISA variables (F 2,51 = 5.981, P = 0.005). Similarly, the corresponding 41-kDa IgG model also contained two LTT-MELISA variables (F 2,57 = 3.700, P = 0.031).
CONCLUSION: It is concluded that the LTT-MELISA appears to be able to detect the response to this antigen. AJCEI
Copyright © 2022.

Entities:  

Keywords:  Flagellin; MELISA; lymphocyte transformation test

Year:  2022        PMID: 36187894      PMCID: PMC9520187     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  42 in total

1.  Diagnostic use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous cases.

Authors:  Basant K Puri; Daniel Rm Segal; Jean A Monro
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  The lymphocyte transformation test for the diagnosis of Lyme borreliosis.

Authors:  V von Baehr
Journal:  Clin Microbiol Infect       Date:  2014-10-29       Impact factor: 8.067

3.  Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.

Authors:  Steve Halligan; Darren Boone; Lucinda Archer; Tariq Ahmad; Stuart Bloom; Manuel Rodriguez-Justo; Stuart A Taylor; Sue Mallett
Journal:  Health Technol Assess       Date:  2021-07       Impact factor: 4.014

4.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

5.  N-terminal amino acid sequence of the Borrelia burgdorferi flagellin.

Authors:  G S Gassmann; R Deutzmann; A Vogt; U B Göbel
Journal:  FEMS Microbiol Lett       Date:  1989-07-01       Impact factor: 2.742

6.  Unconventional diagnostic tests for Lyme borreliosis: a systematic review.

Authors:  A Raffetin; A Saunier; K Bouiller; P Caraux-Paz; C Eldin; S Gallien; R Jouenne; A Belkacem; J Salomon; O Patey; E Talagrand-Reboul; B Jaulhac; A Grillon
Journal:  Clin Microbiol Infect       Date:  2019-07-12       Impact factor: 8.067

Review 7.  Lyme Carditis: From Pathophysiology to Clinical Management.

Authors:  Cinzia Radesich; Eva Del Mestre; Kristen Medo; Giancarlo Vitrella; Paolo Manca; Mario Chiatto; Matteo Castrichini; Gianfranco Sinagra
Journal:  Pathogens       Date:  2022-05-15

8.  A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete.

Authors:  T R Howe; L W Mayer; A G Barbour
Journal:  Science       Date:  1985-02-08       Impact factor: 47.728

Review 9.  Relapsing Fevers: Neglected Tick-Borne Diseases.

Authors:  Emilie Talagrand-Reboul; Pierre H Boyer; Sven Bergström; Laurence Vial; Nathalie Boulanger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

10.  [Lyme borreliosis and Lyme neuroborreliosis - an update].

Authors:  Rick Dersch; Volker Fingerle
Journal:  Dtsch Med Wochenschr       Date:  2021-06-01       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.